Ocular Therapeutix, Inc.

NASDAQ:OCUL

6.1 (USD) • At close May 21, 2024
Bedrijfsnaam Ocular Therapeutix, Inc.
Symbool OCUL
Munteenheid USD
Prijs 6.1
Beurswaarde 944,822,900
Dividendpercentage 0%
52-weken bereik 1.995 - 11.31
Industrie Biotechnology
Sector Healthcare
CEO Mr. Antony Mattessich
Website https://www.ocutx.com

An error occurred while fetching data.

Over Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone

Vergelijkbare Aandelen

Theratechnologies Inc. logo

Theratechnologies Inc.

THTX

1.33 USD

ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc.

CLPT

6.07 USD

4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc.

FDMT

25.15 USD

Verastem, Inc. logo

Verastem, Inc.

VSTM

12.06 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)